Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Pfizer purchased exclusive global commercialization rights for the then-experimental treatment in December 2014 for $295 million upfront and a promise of up to $275 million in milestones
Research Focus: Telomerase activity studies Cellular aging mechanism research Circadian rhythm pathway analysis DNA damage response investigations Melatonin production pathway studies Specifications: Tetrapeptide sequence: Ala-Glu-Asp-Gly Molecular Weight: 390.35 Da Research-grade purity Optimal for long-term stability studies Intended for in-vitro research applications only
Aim for seven to nine hours nightly during treatment periods
Biochemistry, Peptide
Inject the bacteriostatic water slowly into the semaglutide vial, aiming the stream against the inner glass wall never directly at the powder
US$ 24.33
US$ 28.52
US$ 23.71
US$ 25.75
US$ 21.55
US$ 20.92
US$ 25.41
US$ 23.97
